Treatment of suction termination of pregnancy-retained products with misoprostol markedly reduces the repeat operation rate

A six‐year audit of clinical outcomes following the treatment of suction termination of pregnancy‐retained products of conception symptoms with 200 µg of misoprostol orally or sublingually three times a day for six doses showed that it was 93% effective and it reduced the repeat dilation and curetta...

Full description

Saved in:
Bibliographic Details
Published in:Australian & New Zealand journal of obstetrics & gynaecology 2009-10, Vol.49 (5), p.551-553
Main Authors: CHAMBERS, Dennis G., MULLIGAN, Ea C.
Format: Article
Language:English
Subjects:
Abortifacient Agents, Nonsteroidal - administration & dosage
Abortion, Induced - adverse effects
Administration, Sublingual
dilatation and curettage
Female
Humans
misoprostol
Misoprostol - administration & dosage
Patient Satisfaction
Pregnancy
retained products of conception
Retrospective Studies
termination of pregnancy
Treatment Failure
Vacuum Curettage - adverse effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A six‐year audit of clinical outcomes following the treatment of suction termination of pregnancy‐retained products of conception symptoms with 200 µg of misoprostol orally or sublingually three times a day for six doses showed that it was 93% effective and it reduced the repeat dilation and curettage rate by 79.6% (P 
ISSN:0004-8666
1479-828X
DOI:10.1111/j.1479-828X.2009.01043.x